← Back to headlines
Warnings Against Off-Label Use of Diabetes Drug Mounjaro for Diet
Japanese medical societies and pharmaceutical companies are issuing warnings against the use of the Type 2 diabetes drug Mounjaro for weight loss purposes, citing potential health risks despite its promotion on social media and by beauty clinics.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Global Outage Disrupts Microsoft Outlook Email Services
59m ago
Cathie Wood's ARK Invest Buys $53M in Nvidia, Sells Palantir and Buys Rocket Lab and Block
1h ago
FTC and 22 States Sue Amazon Over Alleged Ad Pricing Manipulation
1h ago
Instagram cracks down on unlabeled AI influencers amid Nepal flood disinformation
7h ago